Join ACGT in supporting
scientists engaged in
ground-breaking cell and
gene therapy research for treatments that can
improve the quality of
life and survival for all
cancer patients.
Cell and gene therapies for cancer are treatments that attack only cancer cells. This approach has the potential to replace traditional treatments that can cause adverse side effects on the body. Learn more...
ACGT FELLOW'S RESEARCH OBLITERATES TUMORS IN LEUKEMIA PATIENTS
Dr. Carl June and his team at University of Pennsylvania Abramson Cancer Center are making great strides for the treatment of advanced CLL (chronic lymphocytic leukemia). The clinical trial, funded by ACGT, uses genetically modified versions of the patient's own T cells, and has shown remission for up to a year in a small group of patients, several of whom are in complete remission.
January 2012 - Science Translational Magazine has honored this research as "Paper of the Year 2011".
THE STORY WAS COVERED BY NBC NIGHTLY NEWS ON AUG 10, 2011
NOBEL PRIZE FOR IMMUNOTHERAPY:
DISCOVERIES THAT PAVED THE WAY FOR CELL AND GENE THERAPY!
Diagnosed with pancreatic cancer four years ago, Dr. Ralph Steinman of Rockefeller Institute extended his lifespan by using immunotherapy based on his research using dendritic cells from his own body.
Half of ACGT Fellows are focusing on immunotherapy. Read more...
Every day, ACGT Grantees are making enormous progress in the treatments of Lymphoma, Leukemia, Multiple Myeloma, Neuroblastoma, Breast cancer, Ovarian cancer, Lung cancer, Brain cancer, Pancreatic cancer, and Prostate cancer. View a list of our Grantees.
ACGT is leading the way in bringing molecular medicine directly to patients with more than 17 clinical trials underway. Now, more than ever, we need your support to continue to fund this breakthrough cancer research.
Please donate now.
ACGT is approved by the coalition of the Better Business Bureau and the National Charities Information Bureau. Read more...
Follow us
now on...
Send this page
to a friend